COMPARING DRUG SURVIVAL FOR BIOSIMILAR SB4 ETANERCEPT IN RHEUMATOID ARTHRITIS BOTH ETANERCEPT NAIVE AND NON-MEDICAL SWITCH PATIENTS WITH ETANERCEPT REFERENCE DRUG IN A NORWEGIAN OUT-PATIENT CLINIC. PRELIMINARY RESULTS FROM A MULTI-CENTER STUDY

被引：0
|
作者：
Haugeberg, Glenn [1 ]
Fevang, Bjorg Tilde Svanes [2 ]
Bakland, Gunnstein [3 ]
Rodevand, Erik [4 ]
Diamantopoulos, Andreas [5 ]
机构：
[1] Sorlandet Hosp Kristiansand, Rheumatol, Kristiansand, Norway
[2] Haukeland Hosp, Rheumatol, Bergen, Norway
[3] Univ Hosp North Norway HF, Rheumatol, Tromso, Norway
[4] St Olavs Hosp HF, Rheumatol, Trondheim, Norway
[5] Martina Hansens Hosp, Rheumatol, Baerum, Norway
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.7423
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0146
引用
收藏
页码：1144 / 1145
页数：2
相关论文
共 14 条
  • [1] LONG TERM DRUG SURVIVAL FOR BIOSIMILAR SB4 ETANERCEPT IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND AXIAL SPONDYLOARTHRITIS PATIENTS WITH A NON-MEDICAL SWITCH FROM ETANERCEPT REFERENCE DRUG
    Haugeberg, Glenn
    Fevang, Bjorg Tilde Svanes
    Bakland, Gunnstein
    Rodevand, Erik
    Diamantopoulos, Andreas
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 710 - 711
  • [2] DRUG SURVIVAL AND REASON FOR DROP-OUT IN RHEUMATOID ARTHRITIS PATIENTS WITH A NON-MEDICAL SWITCH FROM ORIGINATOR TO BIOSIMILAR ETANERCEPT - PRELIMINARY DATA FROM A NORWEGIAN MULTICENTER STUDY
    Haugeberg, G.
    Bakland, G.
    Rodevand, E.
    Fevang, B. T.
    Hansen, I. J. W.
    Diamantopoulos, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1383 - 1383
  • [3] Impact of Anti-Drug Antibody and Injection Site Reaction on Efficacy: 24-Week Results from a Phase III Study Comparing SB4 (etanercept biosimilar) with Reference Etanercept in Patients with Rheumatoid Arthritis
    Vencovsky, Jiri
    Emery, Paul
    Keystone, Edward C.
    Ghil, Jeehoon
    Cheong, Soo Yeon
    Hong, Evelyn
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [4] IMPACT OF ANTI-DRUG ANTIBODY AND INJECTION SITE REACTION ON EFFICACY: 24-WEEK RESULTS FROM A PHASE III STUDY COMPARING SB4 (ETANERCEPT BIOSIMILAR) WITH REFERENCE ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Vencovsky, J.
    Emery, P.
    Keystone, E.
    Ghil, J.
    Cheong, S. Y.
    Hong, E. E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 137 - 137
  • [5] Comparison of injection-site reactions between the etanercept biosimilar SB4 and the reference etanercept in patients with rheumatoid arthritis from a phase III study
    Girolomoni, G.
    Feldman, S. R.
    Emery, P.
    Ghil, J.
    Keum, J. W.
    Cheong, S. Y.
    Hong, E.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (03) : E215 - E216
  • [6] 52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritis
    Emery, Paul
    Vencovsky, Jiri
    Sylwestrzak, Anna
    Leszczynski, Piotr
    Porawska, Wieslawa
    Baranauskaite, Asta
    Tseluyko, Vira
    Zhdan, Vyacheslav M.
    Stasiuk, Barbara
    Milasiene, Roma
    Barrera Rodriguez, Aaron Alejandro
    Cheong, Soo Yeon
    Ghil, Jeehoon
    [J]. RHEUMATOLOGY, 2017, 56 (12) : 2093 - 2101
  • [7] A PHASE III RANDOMISED, DOUBLE-BLIND CLINICAL STUDY COMPARING SB4, AN ETANERCEPT BIOSIMILAR, WITH ETANERCEPT REFERENCE PRODUCT (ENBREL®) IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY (24-WEEK RESULTS)
    Vencovsky, J.
    Sylwestrzak, A.
    Leszczynski, P.
    Porawska, W.
    Baranauskaite, A.
    Tseluyko, V.
    Zhdan, V.
    Stasiuk, B.
    Milasiene, R.
    Rodriguez, A. A. Barrera
    Cheong, S. Y.
    Ghil, J.
    Emery, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 467 - 468
  • [8] A Phase III, Randomized, Double-Blind Clinical Study Comparing SB4, an Etanercept Biosimilar, with Etanercept Reference Product (Enbrel®) in Patients with Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy (52-week Results)
    Vencovsky, Jiri
    Sylwestrzak, Anna
    Leszczynski, Piotr
    Porawska, Wieslawa
    Baranauskaite, Asta
    Tseluyko, Vira
    Zhdan, Vyacheslav
    Stasiuk, Barbara
    Milasiene, Roma
    Barrera Rodriguez, Aaron Alejandro
    Cheong, Soo Yeon
    Ghil, Jeehoon
    Emery, Paul
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [9] Evaluation of Radiographic Progression By Disease Activity States in Patients with Rheumatoid Arthritis Treated with SB4 or Reference Etanercept: Results from a Phase III Study
    Emery, Paul
    Vencovsky, Jiri
    Ghil, Jeehoon
    Cheong, Soo Yeon
    Hong, Evelyn
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [10] Real-World Drug Persistence of GP2015, an Etanercept Biosimilar, in Patients with Rheumatoid Arthritis: Results from the Multi-Country COMPACT Study
    Schmalzing, Marc
    Both, Charlotte
    Brueckmann, Ines
    de Toro Santos, Javier
    Sheeran, Tom
    Kellner, Herbert
    Askari, Ayman
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4296 - 4298
12